Skip to main content
. 2015 Feb 23;5:8528. doi: 10.1038/srep08528

Table 4. General information about LPV/r treatment of pregnant women.

  Age at delivery  (year) Baseline CD4+ count  (cells/mm3) Baseline viral load (log10 copies/mL) Vaginal delivery (%) MTCT (%) PD (%) LBW (%)
Roberts SS et al.19 13–48 NA NA NA NA 13.4 19.2
Senise J et al.20 29.4 (16–41)# 289 (13–811)* 4.28 (0– ≥ 5.88)* 11 0.8 25.0 20.3
de Vincenzi I21 27 (24–31)* 336 (282–408) 4.23 (3.66–4.75) 89 1.8 13.2 11.4
Azria E et al.22 32.4 ± 5.0$ 361 (8–858)* 3.6 (<1.7–5.4)* 45 1.0 21.0 17.0
Peixoto MF et al.23 29.6 ± 5.5$ 486.1 ± 292.7 $ 2.6 ± 1.0$ NA 0.6 9.8 20.2
Peixoto MF et al.23 27.1 ± 6.4$ 535.4 ± 303.9 $ 3.0 ± 0.7$ NA 0.7 8.7 15.9
Villatoro CM et al.24 26 (16–43)* 329 (2–1034)# 4.82 (0–6.26)# 4 1.4 10.6 NA
Shapiro RL et al.25 25 403 (297–514) 3.96 (3.34–4.60) NA NA 14.8 13.1

#Mean (range);

*median (range);

median (quartiles);

$mean ± standard deviation.

MTCT: mother-to-child transmission; PD: preterm delivery (<37 weeks gestation); LBW: low birth weight (<2,500 g).